廣發證券舉辦“新一輪央國企改革與中國特色估值體系建設”論壇及上市公司交流會
格隆匯5月16日丨近日,由廣發證券主辦的“新一輪央國企改革與中國特色估值體系建設”論壇及上市公司交流會在北京成功舉辦。各金融機構和上市公司代表、戰略客户、高淨值客户、產業專家、行業資深人士等500餘人到場參會。廣發證券副總經理張威出席論壇並致辭表示,中國式現代化的恢宏背景下,作為公有制經濟的中流砥柱,央國企堪稱“國之重器”,承擔了重大歷史使命。2023年是新一輪國企改革的開幕之年,央國企有望通過業務的轉型升級,帶動盈利端的長足改善,推動央國企整體的估值重塑。廣發證券將一如既往保持家國情懷,秉持“以價值創造成就金融報國之夢”的使命感,發掘中國經濟、中國資產的價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.